Your browser doesn't support javascript.
loading
Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD.
Muiser, Susan; Imkamp, Kai; Seigers, Dianne; Halbersma, Nynke J; Vonk, Judith M; Luijk, Bart H D; Braunstahl, Gert-Jan; van den Berg, Jan-Willem; Kroesen, Bart-Jan; Kocks, Janwillem W H; Heijink, Irene H; Reddel, Helen K; Kerstjens, Huib A M; van den Berge, Maarten.
Afiliação
  • Muiser S; Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands s.muiser@umcg.nl.
  • Imkamp K; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Seigers D; Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Halbersma NJ; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Vonk JM; Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Luijk BHD; Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Braunstahl GJ; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • van den Berg JW; Department of Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Kroesen BJ; Department of Pulmonology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Kocks JWH; Department of Pulmonology, Franciscus Gasthuis, Rotterdam, The Netherlands.
  • Heijink IH; Department of Pulmonology, Isala Hospital, Zwolle, The Netherlands.
  • Reddel HK; Laboratory of Medical Immunology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Kerstjens HAM; Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • van den Berge M; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Thorax ; 78(5): 451-458, 2023 05.
Article em En | MEDLINE | ID: mdl-36725331

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Broncodilatadores / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Thorax Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Broncodilatadores / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Thorax Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda